Vancouver, British Columbia (FSCwire) - Liberty Biopharma Inc. (“Liberty Biopharma” or the “Company”) (TSXV: LTY), a diversified healthcare and medical digital, green and clean technology company is pleased to announce that it has completed all of the steps for the acquisition of HooXi as announced on June 28, 2018 and in the Management Information Circular dated July 25, 2018.  The name of the Company has changed to HooXi Network Inc. and the shares of the Company are anticipated to begin trading on the TSXV on October 3, 2018, under the symbol “HXI”.

About HooXi Network Inc. (formerly Liberty Biopharma Inc.)

HooXi Network is a diversified healthcare and medical digital, green and clean technology active in global strategic partnerships and in-licensing of technologies and assets for rapid growth and high value solutions.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The information contained herein is not an offer to buy or sell, nor is it a solicitation of an offer to buy or sell, any security of the Company. The Company’s securities have not been and will not be registered under the applicable securities laws of the United States or any other jurisdiction. None of the U.S. Securities and Exchange Commission, any U.S. state securities commission or any other governmental body or self-regulatory organization has approved or disapproved the Securities, nor have they passed upon or endorsed the merits of the securities. Any representation to the contrary is a criminal offence in the United States.

Forward Looking Statements: 

Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of Liberty or HooXi. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management’s expectations and intentions with respect to the agreements with HooXi. These statements generally can be identified by use of forward-looking terms such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results anticipated in any forward-looking statements. HooXi does not assume any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements, other than as required by applicable securities laws. 

For further information, please contact: 

Alan Tam, CPA, CA

CFO, HooXi Network Inc.

(604)377-7575

To view the original release, please click here

To follow Liberty Biopharma Inc. on your favorite social media platform or financial websites, please click on the icons below.

Maximum News Dissemination by FSCwire. https://www.fscwire.com

Copyright © 2018 FSCwire